Australian Water Utilities Stock News

CSL recently reported five-year Phase 3 HOPE-B data in NEJM and at the ASH meeting, showing HEMGENIX’s durable factor IX activity, sustained bleed reduction, and continued freedom from routine prophylaxis in adults with hemophilia B. The results reinforce HEMGENIX’s position as the only commercially available gene therapy for adult hemophilia B, with long-term safety and efficacy data that may shape how patients and clinicians view one-time gene therapy versus ongoing prophylaxis. We’ll now...

With a price-to-sales (or "P/S") ratio of 3.3x Raiz Invest Limited ( ASX:RZI ) may be sending very bullish signals at...

It is a pleasure to report that the IODM Limited ( ASX:IOD ) is up 43% in the last quarter. But that doesn't change the...

When close to half the companies operating in the Consumer Services industry in Australia have price-to-sales ratios...

There wouldn't be many who think Jatcorp Limited's ( ASX:JAT ) price-to-sales (or "P/S") ratio of 0.4x is worth a...

We wouldn't blame Catalyst Metals Limited ( ASX:CYL ) shareholders if they were a little worried about the fact that...

Most readers would already be aware that Whitehaven Coal's (ASX:WHC) stock increased significantly by 21% over the past...

Key Insights Tesoro Gold's significant individual investors ownership suggests that the key decisions are influenced by...

Clinuvel Pharmaceuticals (ASX:CUV) is in the spotlight after unveiling a major expansion of its Vallaurix innovation hub in Singapore. The company has announced a five year push backed by the Economic Development Board to accelerate advanced peptide drug development. See our latest analysis for Clinuvel Pharmaceuticals. The market seems to be warming to that strategy, with a 30 day share price return of 17.15% and a 90 day gain of 21.11%. However, the five year total shareholder return...

Champion Iron's (ASX:CIA) stock is up by a considerable 35% over the past three months. However, we wonder if the...

Some Kip McGrath Education Centres Limited ( ASX:KME ) shareholders may be a little concerned to see that insider Storm...

Insiders who bought Cryosite Limited ( ASX:CTE ) in the last 12 months may probably not pay attention to the stock's...

Key Insights The considerable ownership by individual investors in Prospect Resources indicates that they collectively...

Anyone interested in Imdex Limited ( ASX:IMD ) should probably be aware that the Independent Non-Executive Chairman...

Insiders were net sellers of Desane Group Holdings Limited's ( ASX:DGH ) stock during the past year. That is, insiders...

Investors may wish to note that the Non Executive Independent Chairman of Beforepay Group Limited , Brian Hartzer...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Ramelius Resources (ASX:RMS) has kicked off a sizeable buyback, committing up to A$250 million to repurchase roughly 4% of its shares by mid 2027. This move is a clear signal of confidence at the board level. See our latest analysis for Ramelius Resources. The buyback comes after a powerful run in the shares, with a year to date share price return of about 69% and a three year total shareholder return above 300%. This suggests momentum is still firmly with the bulls, even if short term moves...

As the Australian market experiences a mixed performance with materials leading and IT and industrials lagging, investors are keenly observing sector shifts. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

Brightstar Resources has reported outstanding high-grade gold drilling results at its Sandstone Hub in Western Australia, including standout intercepts at the Bull Oak and Havilah deposits, while also confirming the past resignation of Non-Executive Director Ashley Fraser effective 2 December 2025. By running six drill rigs and feeding new data into an updated Pre-Feasibility Study due in 2026, Brightstar is sharpening its understanding of Sandstone Hub’s economic potential and its role as a...

Charter Hall Group has completed a 42.28 cents per security capital reallocation between Charter Hall Limited and Charter Hall Property Trust, alongside approving a 24.83 cents half-year distribution (85% franked) for the six months to 31 December 2025, payable on 27 February 2026. This mix of internal capital reshaping and a higher, largely franked distribution highlights management’s focus on capital efficiency while supporting tax-effective income for investors. We’ll now examine how the...

In recent days, Iluka Resources withdrew its 2025 synthetic rutile production guidance due to uncertainty over a key UK customer agreement, prompting analyst downgrades and highlighting ongoing operational and market disruptions affecting its mineral sands and rare earths business. This shift draws attention to how sensitive Iluka’s outlook is to individual customer contracts, production reliability, and evolving tariffs and export controls in its core markets. We’ll now examine how the...

Mesoblast (ASX:MSB) steps into the spotlight this week as CEO Silviu Itescu presents at the Piper Sandler 37th Annual Healthcare Conference, and traders are watching for fresh color on strategy and late stage trials. See our latest analysis for Mesoblast. That anticipation has arrived on the back of a strong near term rebound, with a 1 month share price return of 27.03 percent and a 1 year total shareholder return of 65.88 percent, even though the year to date share price return remains...

Bapcor (ASX:BAP) has become a lightning rod for investor anxiety after slashing its FY26 profit guidance again, flagging a first half loss and fresh pressure in its core Trade division. See our latest analysis for Bapcor. The guidance cut has effectively reset expectations, with the 1 day share price return of minus 21.28 percent capping a year to date share price decline of 60.04 percent and a 5 year total shareholder return of minus 69.63 percent. This signals seriously fading momentum...